ES2090140T3 - Peptidos terapeuticos. - Google Patents

Peptidos terapeuticos.

Info

Publication number
ES2090140T3
ES2090140T3 ES90913117T ES90913117T ES2090140T3 ES 2090140 T3 ES2090140 T3 ES 2090140T3 ES 90913117 T ES90913117 T ES 90913117T ES 90913117 T ES90913117 T ES 90913117T ES 2090140 T3 ES2090140 T3 ES 2090140T3
Authority
ES
Spain
Prior art keywords
amino acid
active site
acid residue
peptide
peptide bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913117T
Other languages
English (en)
Inventor
David H Coy
Jacques-Pierre Moreau
Sun Hyuk Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Ipsen Bioscience Inc
Original Assignee
Tulane University
Ipsen Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University, Ipsen Bioscience Inc filed Critical Tulane University
Application granted granted Critical
Publication of ES2090140T3 publication Critical patent/ES2090140T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN ANALOGO LINEAL (ES DECIR, NO CICLICO) DE UN PEPTIDO DE LIBERACION DE LA GASTRINA DE MAMIFEROS (GRP) O DE LA BOMBESINA DE ANFIBIOS BIOLOGICAMENTE ACTIVO QUE TIENE UN LADO ACTIVO Y UN LADO ENLAZANTE RESPONSABLE DEL ENLACE DEL PEPTIDO A UN RECEPTOR SOBRE UNA CELULA BLANCA. LA DIVISION DE UN ENLACE PEPTIDO EN EL LADO ACTIVO DE LA BOMBOSINA QUE OCURRE DE MANERA NATURAL O DEL GRP ES INNECESARIA PARA UNA ACTIVIDAD BIOLOGICA IN VIVO. EL ANALOGO TIENE UNO DE LOS CAMBIOS SIGUIENTES: (A) UNA ELIMINACION DEL RESIDUO AMINOACIDO DENTRO DEL LADO ACTIVO Y UN CAMBIO DE UN RESIDUO AMINOACIDO FUERA DEL LADO ACTIVO, (B) UNA SUSTITUCION DE LOS DOS RESIDUOS AMINOACIDOS DENTRO DEL LADO ACTIVO CON UN AMINOACIDO SINTETICO, UN BETA-AMINOACIDO O UN RESIDUO GAMMA-AMINOACIDO, O (C) UN ENLACE NO PEPTIDO EN LUGAR DE UN ENLACE PEPTIDO ENTRE UN RESIDUO AMINOACIDO DEL LADO ACTIVO Y UN RESIDUO AMINOACIDO ADYACENTE.
ES90913117T 1989-08-21 1990-08-17 Peptidos terapeuticos. Expired - Lifetime ES2090140T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39716989A 1989-08-21 1989-08-21
US07/502,438 US5084555A (en) 1989-08-21 1990-03-30 An octapeptide bombesin analog

Publications (1)

Publication Number Publication Date
ES2090140T3 true ES2090140T3 (es) 1996-10-16

Family

ID=27015776

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913117T Expired - Lifetime ES2090140T3 (es) 1989-08-21 1990-08-17 Peptidos terapeuticos.

Country Status (12)

Country Link
US (1) US5084555A (es)
EP (1) EP0489089B1 (es)
JP (1) JPH04506664A (es)
AT (1) ATE139540T1 (es)
AU (1) AU648037B2 (es)
CA (1) CA2064896A1 (es)
DE (1) DE69027533T2 (es)
DK (1) DK0489089T3 (es)
ES (1) ES2090140T3 (es)
FI (1) FI920737A0 (es)
NO (1) NO302619B1 (es)
WO (1) WO1991002746A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US5767236A (en) * 1990-05-09 1998-06-16 Biomeasure, Inc. Linear therapeutic peptides
US5620959A (en) * 1990-07-31 1997-04-15 Glaxo Wellcome Inc. Bombesin antagonists
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
AU4238493A (en) * 1992-05-08 1993-12-13 Thomas Jefferson University IGF-1 analogs
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
GB0009918D0 (en) * 2000-04-20 2000-06-07 Rose Keith Covalent capture facilitating purification of polypeptides
US20030013637A1 (en) * 2001-05-18 2003-01-16 Hideto Ikushima Novel anti-autoimmune composition by inhibition of GRF action
AU2003262878A1 (en) * 2002-08-26 2004-03-11 Wisconsin Alumni Research Foundation HETEROGENEOUS FOLDAMERS CONTAINING Alpha, Beta, AND/OR Gamma-AMINO ACIDS
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
AU2004232314B2 (en) 2003-04-22 2007-11-22 Ipsen Pharma S.A.S. Peptide vectors
JPWO2006115135A1 (ja) 2005-04-21 2008-12-18 アステラス製薬株式会社 過敏性腸症候群治療剤
KR20090058553A (ko) * 2006-09-08 2009-06-09 바이엘 쉐링 파마 악티엔게젤샤프트 18ｆ 표지된 작용제에 대한 화합물 및 방법
MX2009003617A (es) * 2006-10-02 2009-04-22 Bayer Schering Pharma Ag Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet).
BRPI0721424A2 (pt) * 2007-03-01 2014-03-25 Bayer Schering Pharma Ag Métodos de radiofluoração
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
AU2009259033B2 (en) 2008-06-12 2013-11-07 Ipsen Bioinnovation Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (en) 2008-12-18 2010-06-23 University Of Miami Polypeptide bombesin antagonists
WO2020163833A2 (en) 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
WO2020235932A1 (ko) * 2019-05-21 2020-11-26 주식회사 아이바이오코리아 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) * 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4650661A (en) * 1982-09-15 1987-03-17 Aktiebolaget Hassle Enzyme inhibitors
ATE37552T1 (de) * 1982-10-18 1988-10-15 Ici Plc Peptid- und pseudopeptid-derivate.
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
WO1989002897A1 (en) * 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds

Also Published As

Publication number Publication date
NO920678D0 (no) 1992-02-20
EP0489089A1 (en) 1992-06-10
WO1991002746A1 (en) 1991-03-07
DE69027533T2 (de) 1996-12-19
CA2064896A1 (en) 1991-02-22
US5084555A (en) 1992-01-28
DE69027533D1 (de) 1996-07-25
AU648037B2 (en) 1994-04-14
AU6294090A (en) 1991-04-03
ATE139540T1 (de) 1996-07-15
EP0489089A4 (en) 1992-06-24
FI920737A0 (fi) 1992-02-20
NO302619B1 (no) 1998-03-30
DK0489089T3 (da) 1996-07-29
NO920678L (no) 1992-04-06
JPH04506664A (ja) 1992-11-19
EP0489089B1 (en) 1996-06-19

Similar Documents

Publication Publication Date Title
DK0489089T3 (da) Terapeutiske peptider
HK1010785A1 (en) Therapeutic peptides
ES2065336T3 (es) Peptidos terapeuticos.
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
AU5258898A (en) Mutant forms of fas ligand and uses thereof
ES2062514T5 (es) Sistema de procesamiento de levadura que comprende un aminoacido cargado negativamente adyacente al sitio de procesamiento.
ES526201A0 (es) Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria
EP0557418A4 (en) A -g(b)-type transforming growth factor
HU906872D0 (en) Therapeutic peptides
DE69528531D1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
Kiso et al. Neo‐kyotorphin (Thr—Ser—Lys—Tyr—Arg), a new analgesic peptide
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
PT95057A (pt) Processo para a preparacao de peptidos terapeuticos
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
ECSP003683A (es) Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489089

Country of ref document: ES

FG2A Definitive protection

Ref document number: 489089

Country of ref document: ES